Winton Group LTD Aerie Pharmaceuticals Inc Transaction History

Winton Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 05, 2019	SELL	$33.0 - $60.04 $248,589 - $452,281	-7,533 Closed	0 $0
Q3 2018 Nov 02, 2018	SELL	$56.15 - $73.9 $31,219 - $41,088	-556 Reduced 6.87%	7,533 $0
Q2 2018 Aug 20, 2018	SELL	$47.85 - $70.45 $444,191 - $653,987	-9,283 Reduced 53.44%	8,089 $0
Q1 2018 May 21, 2018	BUY	$51.15 - $61.0 $888,577 - $1.06 Million	17,372 New	17,372 $0

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.